In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...